NuvaRing Lawsuit News: NuvaRing Lawsuits Recently Filed in the U.S. District Court for the Southern District of Illinois

sgodar — Wed, 12 Jun 2013 13:49:57 +0000

According to a recent Madison-St. Clair Record article, NuvaRing lawsuits have recently been filed in the U.S. District Court for the Southern District of Illinois charging five defendants, among them Organon USA, with failure to properly warn healthcare providers and patients about risks of NuvaRing use. Health complications commonly cited with the use of the NuvaRing contraceptive device include blood clots, deep vein thrombosis (DVT), stroke, heart attack, pulmonary embolism, blood clots, and in some cases, death. According to a Danish study published in May 2012 in the British Medical Journal, researchers discovered that women using a vaginal ring contraceptive device, such as the NuvaRing, experienced a significantly increased risk of developing blood clots. In addition to the NuvaRing lawsuits in the U.S. District Court in Illinois, there is also a NuvaRing multidistrict litigation (MDL), known as In re: NuvaRing Products Liability Litigation MDL No. 1964, which is being heard in the U.S. District Court of the Eastern District of Missouri. The NuvaRing MDL is being presided over by U.S. District Judge Rodney W. Sippel. The Madison-St. Clair Record article has deemed the NuvaRing lawsuits recently filed in Illinois “tag-along” lawsuits, meaning they will be significantly influenced by the NuvaRing MDL. NuvaRing attorneys at Carey Danis & Lowe are interested in following the cases in both U.S. District Courts. Carey Danis & Lowe NuvaRing lawyers continue to hear from women who have been injured by the NuvaRing contraceptive device. Furthermore, they are currently offering free legal evaluations of NuvaRing cases, and can assist in filing a NuvaRing lawsuit. If you or someone you love has been injured by Organon and Merck's NuvaRing contraceptive device, contact a pharmaceutical product liability lawyer at Carey Danis & Lowe today. Call Carey Danis & Lowe at 800.721.2519 or submit a personal injury claim form.

The post NuvaRing Lawsuit News: NuvaRing Lawsuits Recently Filed in the U.S. District Court for the Southern District of Illinois appeared first on .

Vaginal Mesh Lawsuit News: Carey Danis & Lowe Remarks on West Virginia Vaginal Mesh MDLs Complaint Form Update

sgodar — Wed, 12 Jun 2013 13:43:21 +0000

As the parties involved in the five vaginal mesh multidistrict litigation (MDL) cases recently met about removing certain entities from plaintiffs' cases, the court has followed through on the name removal agreement with its revised complaint forms. The U.S. District Court for the Southern District of West Virginia recently filed a revised short form complaint and an amended short form complaint for plaintiffs who are filing a new vaginal mesh lawsuit or updating their case in their respective MDL. The update to complaint forms is detailed in pretrial order number fifty. According to Carey Danis & Lowe vaginal mesh lawyers, modifying the complaint forms to reflect the removal of Endo and Coloplast entities will significantly assist plaintiffs who are currently filing a vaginal mesh lawsuit against one of the five medical device manufacturers. The update ensures that plaintiffs and their legal counsel will use the correct nomenclature when referencing a manufacturer in future complaint forms, and thus, lead to a more efficient legal process. The five West Virginia transvaginal mesh MDLs are being presided over by U.S. District Judge Joseph R. Goodwin. The cases are In Re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation MDL No. 2327; In Re: C. R. Bard, Inc., Pelvic Repair System Products Liability Litigation MDL No. 2187; In Re: American Medical Systems, Inc., Pelvic Repair System Products Liability Litigation MDL No. 2325; In Re: Boston Scientific Corp. Pelvic Repair System Products Liability Litigation MDL No. 2326; and In Re: Coloplast Corp. Pelvic Support Systems Products Liability Litigation MDL No. 2387. Carey Danis & Lowe vaginal mesh lawyers hear from women every day about injuries allegedly linked to the use of a vaginal mesh product, such as the Ethicon Gynecare Prolift. Along with the Gynecare Prolift, vaginal mesh lawyers at Carey Danis & Lowe continue to investigate what injured parties claim is the defective nature of the Gynecare Prolift and other vaginal mesh products. Women who have filed vaginal mesh lawsuits have claimed injury from vaginal mesh erosion, vaginal mesh contraction, infection, and severe pelvic pain. Quite often, women have had to undergo numerous surgeries to remove and repair the damage caused by transvaginal mesh, and in some cases, the damage cannot be easily fixed. If you or someone you love has been injured by a transvaginal mesh product, contact an experienced transvaginal mesh lawyer at Carey Danis & Lowe. Our lawyers will help you understand your legal options, provide you with a free legal evaluation, and can assist in filing a vaginal mesh lawsuit. Contact Carey Danis & Lowe today by calling 800.721.2519 or by submitting a personal injury claim form.

The post Vaginal Mesh Lawsuit News: Carey Danis & Lowe Remarks on West Virginia Vaginal Mesh MDLs Complaint Form Update appeared first on .

Mirena IUD Lawsuit News: Mirena IUD Lawsuits Consolidated into Multicounty Litigation in New Jersey

sgodar — Wed, 12 Jun 2013 13:38:48 +0000

Mirena IUD lawsuits filed in New Jersey were recently consolidated into a multicounty litigation (MCL) in mid-May, according to court documents filed in the Superior Court of New Jersey in Bergen County. Judge Brian R. Martinotti will oversee the Mirena IUD proceedings. The case is In Re: Mirena Litigation Case No. 297. Both parties are scheduled to meet for an initial conference on June 17, 2013. On the agenda for the conference is a discussion of how to coordinate with the Mirena IUD multidistrict litigation (MDL) No. 2434 in the U.S. District Court for the Southern District of New York. According to a Reuters report on the Mirena IUD MCL in New Jersey, there are approximately 113 cases that have been filed in the Bergen County court as of May 20, 2013. Plaintiffs in the Mirena MCL and the Mirena MDL have filed their Mirena IUD lawsuits alleging that Bayer neglected to sufficiently warn users that the plastic contraceptive device could cause serious injury through uterus perforation and device migration. Mirena IUD lawyers at Carey Danis & Lowe view the multicounty litigation formation as a positive move, as it will allow for an expedited legal process without redundancy for both parties. Carey Danis & Lowe Mirena IUD lawyers encourage women who used the Mirena IUD and suffered an injury to contact our Mirena IUD law firm today for a free legal evaluation. Call a Carey Danis & Lowe Mirena IUD lawyer at 800.721.2519 or submit a personal injury claim.

The post Mirena IUD Lawsuit News: Mirena IUD Lawsuits Consolidated into Multicounty Litigation in New Jersey appeared first on .

Transvaginal Mesh Lawyers at Carey Danis & Lowe Report on Ethicon MDL 2327 Pretrial Order 48

sgodar — Wed, 12 Jun 2013 13:35:26 +0000

The latest development in the Ethicon multidistrict litigation (MDL) in the U.S. District Court for the Southern District of West Virginia, U.S. District Judge Joseph R. Goodwin filed pretrial order 48 about dismissing certain Coloplast Corp. entities from all pending cases. Filed on May 28, the pretrial order in Ethicon MDL 2327 reports on the defendants' request for the removal of certain Coloplast entities from plaintiffs' cases in all transvaginal mesh lawsuits consolidated into the five MDLs presided over by Judge Goodwin. Though the pretrial order will have more of an affect on the Coloplast MDL 2387 itself, due to the closely related injuries detailed by plaintiffs, pretrial orders filed in one transvaginal mesh MDL in the West Virginia court are often filed in all of the MDLs. The most recent pretrial order does not mean that the Coloplast MDL is being disbanded. Rather, it simply means that any mention of Coloplast subsidiaries, such as Coloplast A/S, Coloplast Manufacturing US, LLC, and Porges S.A., will be removed from plaintiffs' cases. Like Ethicon's Gynecare Prolift vaginal mesh, Coloplast's bladder sling has been linked to erosion, contraction, severe pelvic pain, infection, and other debilitating health complications. Following almost 3,000 adverse event reports citing problems with vaginal mesh implants, the U.S. Food and Drug Administration (FDA) released a safety communication in July 2011 noting their continuing review of vaginal mesh products and studies. According to the FDA's review, the most frequently reported health complication related to vaginal mesh involves vaginal mesh erosion. The FDA communicated that to resolve vaginal mesh erosion, women underwent numerous surgeries, and even then, the vaginal mesh implant could not be entirely removed, leaving women in extreme pain and discomfort. Transvaginal mesh lawyers at Carey Danis & Lowe are currently investigating vaginal mesh cases, and encourage individuals who have been injured by a vaginal mesh product, whether Ethicon's Gynecare Prolift, Coloplast's bladder slings, or another product, to contact one of our personal injury lawyers today for a free legal consultation. Carey Danis & Lowe can also assist with filing vaginal mesh lawsuits. Contact Carey Danis & Lowe today by calling 800.721.2519 or by submitting a personal injury claim form.

The post Transvaginal Mesh Lawyers at Carey Danis & Lowe Report on Ethicon MDL 2327 Pretrial Order 48 appeared first on .

NuvaRing Lawsuit News from Carey Danis & Lowe NuvaRing Law Firm: Seven Cases Removed from NuvaRing Multicounty Litigation in New Jersey

sgodar — Wed, 22 May 2013 16:40:25 +0000

Carey Danis & Lowe, a NuvaRing law firm representing individuals who have been injured by the contraceptive device, is currently following the NuvaRing multicounty litigation (MCL) taking place in New Jersey. In mid-April a Superior Court Judge in Bergen County New Jersey dismissed seven cases from the Nuvaring MCL. According to the summary judgment order, the seven cases were dismissed from the MCL on the grounds that the plaintiffs in each NuvaRing lawsuit did not provide sufficient evidence connecting their injuries to the use of the NuvaRing contraceptive device. Though bellwether trials in the New Jersey NuvaRing MCL have been interrupted temporarily during this case dismissal process, there are approximately over 200 more cases pending in the Nuvaring MCL. In such a large pool of cases, finding a strong NuvaRing case demonstrating a firm connection between the NuvaRing and blood clots is very possible. In addition to the New Jersey NuvaRing MCL, NuvaRing lawsuits have been consolidated into a multidistrict litigation (MDL) in the U.S. District Court fo the Eastern District of Missouri. There have been discussions of bellwether trials scheduled for October in the NuvaRing MDL. Plaintiffs in the NuvaRing MCL in New Jersey and the NuvaRing MDL in Missouri filed their lawsuits against Merck citing the pharmaceutical company's failure to adequately warn about the blood clot risks associated with use of their contraceptive device. Carey Danis & Lowe NuvaRing lawyers are encouraging individuals who have been injured by the NuvaRing to contact one of our lawyers today for a free legal evaluation and for assistance in filing a NuvaRing lawsuit. Contact Carey Danis & Lowe today by calling 800.721.2519 or submit a legal claim form.

The post NuvaRing Lawsuit News from Carey Danis & Lowe NuvaRing Law Firm: Seven Cases Removed from NuvaRing Multicounty Litigation in New Jersey appeared first on .

Carey Danis & Lowe Actos Lawyers Comment on Annulled Cooper v. Takeda Compensatory Award

sgodar — Wed, 22 May 2013 16:38:06 +0000

Carey Danis & Lowe Actos lawyers were optimistic last week when plaintiff Jack Cooper received a compensatory award in the amount of $6.5 million. However, it appears that California Superior Court Judge Kenneth Freeman has annulled Cooper's award, according to Bloomberg. Judge Freeman made his ruling to void the $6.5 million compensatory award in Cooper v. Takeda following an argument from Takeda claiming lack of evidence connecting Actos and bladder cancer in the plaintiff. The plaintiff and his lawyers are seeking an appeal of Judge Freeman's ruling. Cooper's Actos lawsuit was the first to go to trial of approximately 3,000 cases. Individuals who have been injured by Actos have filed their Actos lawsuits alleging that Takeda failed to warn regulators and healthcare providers about the bladder cancer risks associated with use of the diabetes medication. Despite the nullification of Cooper's compensatory award, Carey Danis & Lowe Actos lawyers are still confident that the Japanese pharmaceutical company is guilty of wrongdoing. Carey Danis & Lowe encourages individuals who have been injured by Actos use to still seek legal counsel. Our Actos lawyers are offering free legal evaluations, and can assist in filing an Actos lawsuit. Contact a Carey Danis & Lowe Actos lawyer today by calling 800.721.2519 or by submitting a legal claim form.

The post Carey Danis & Lowe Actos Lawyers Comment on Annulled Cooper v. Takeda Compensatory Award appeared first on .

Chicago DePuy Hip Trial Jury Rules in Favor of Johnson & Johnson and DePuy

sgodar — Wed, 22 May 2013 16:35:10 +0000

In delivering their verdict on March 16, a jury in the Chicago DePuy Hip trial ruled in Johnson & Johnson and DePuy's favor. In an article from the New York Times, the jury released a verdict stating that neither Johnson & Johnson nor DePuy engaged in a misleading marketing campaign to promote the metal-on-metal hip implant. In contrast to the Chicago DePuy Hip trial, in the first DePuy ASR Hip lawsuit to go to trial in California, the plaintiff Loren Kransky was awarded a compensatory award of $8.3 million. With two DePuy ASR Hip lawsuits settled, Johnson & Johnson faces another 10,000 cases, some of which have been consolidated into a multidistrict litigation (MDL) in Ohio. Carey Danis & Lowe DePuy ASR Hip lawyers will continue to represent clients who have been injured by the defective metal-on-metal hip implant because the evidence uncovered in our investigations indicates that the DePuy ASR Hip implant causes serious injury. DePuy ASR Hip lawyers at Carey Danis & Lowe encourage individuals who have been injured by the DePuy ASR Hip implant to contact one of our experienced trial lawyers for a free legal evaluation about your case, and for assistance in filing a DePuy ASR Hip lawsuit. Contact Carey Danis & Lowe today by calling 800.721.2519 or by submitting a legal claim form.

The post Chicago DePuy Hip Trial Jury Rules in Favor of Johnson & Johnson and DePuy appeared first on .

Cooper v. Takeda Jury Presented with Plaintiff Closing Argument Linking Actos and Bladder Cancer

sgodar — Fri, 17 May 2013 12:17:58 +0000

Takeda Pharmaceuticals, the Japanese pharmaceutical giant responsible for the development and marketing of the diabetes drug Actos, concealed the association between Actos and bladder cancer, a jury was recently told in an Actos trial. ccording to a Bloomberg Businessweek report on the Actos trial being heard in Los Angeles, as early as 2004, Takeda knew about the associated between Actos and bladder cancer. Furthermore, with this awareness, the Japanese pharmaceutical company failed to inform the U.S. Food and Drug Administration (FDA), according to the plaintiffs lawyer in the case, Michael Miller. Closing arguments in the Actos lawsuit were delivered from Miller on April 15, with the jury moving into deliberation on or after April 16 following closing statements from Takeda's lawyers. Due to Cooper's ailing state, Takeda's lawyers have pointed again and again to Cooper's health being to blame for his bladder cancer, not Actos. It will be interesting to see if this argument holds any weight during jury deliberation. The case is Cooper v. Takeda, and is being heard in a California Superior Court in Los Angeles by Judge Kenneth Freeman. As the plaintiff, Jack Cooper, is in poor health, his Actos lawsuit was given priority in going to trial. Once Cooper's case is settled, Takeda still faces approximately 3,000 more Actos lawsuits, according to a Bloomberg Businessweek report. The FDA approved Actos in 1999, and since then has ordered Takeda to continually update the drug's label in order to provide adequate warnings about various health risks associated with Actos use. The current Actos drug label lists a warning about bladder cancer noting that in patients who have used Actos for longer periods, the risk of bladder cancer has increased considerably. Carey Danis & Lowe Actos lawyers believe that the Cooper Actos case will be representative of and influence future Actos trials and lawsuits. With the evidence brought before the jury in the Cooper case about the dangers of taking Actos, our Actos lawyers believe that injured parties deserve justice and compensation, especially in cases where patients take a drug believing there to be minimal risks, but in reality, these risks have been concealed, resulting in serious harm and injury. If you or a loved one has been injured by Actos, contact a Carey Danis & Lowe Actos lawyer by calling 800.721.2519 or by submitting a legal claim form.

The post Cooper v. Takeda Jury Presented with Plaintiff Closing Argument Linking Actos and Bladder Cancer appeared first on .

Bayer Loses Yaz Patent in Federal Court of Appeals: Generic Yaz Versions Begin (Stealing) Marketshare

sgodar — Wed, 08 May 2013 14:49:45 +0000

Bayer was recently dealt a setback in a Federal Court of Appeals in Washington. Their patent on Yaz, a contraceptive pill, was deemed to no longer be worthy of patent protection. Bayer's patent on Yaz expires in June 2014. As a result of this ruling, Actavis Inc. and Novartis AG can sell generic versions of the birth control pill. Though the ruling now gives other pharmaceutical companies the ability to legally compete against Bayer in the drospirenone contraceptive pill market, generic and inexpensive versions of Yaz-like drugs are driving Bayer's profits significantly lower. In fact, Bayer stated that Yaz sales fell by 6.9 percent in the fourth quarter alone, according to Bloomberg Businessweek. The Bayer Yaz patent decision was decided in the U.S. Court of Appeals for the Federal Circuit in Washington. The case is Bayer Healthcare Pharma v. Sandoz Inc. Bayer is currently seeking an appeal. Though the drop in Yaz sales may be related to increasing competition from generic versions of drospirenone, Yaz has also been put in the negative spotlight for the contraceptive drug's association with health risks, specifically blood clots, stroke, deep vein thrombosis, and in some cases, these severe Yaz side effects have proven to be fatal. According to a Bloomberg article, Bayer spent $1.57 billion in 2012 towards legal costs in Yaz and Yasmin lawsuits. Yaz lawyers at Carey Danis & Lowe recognize that the loss of Bayer's patent will introduce generic, inexpensive versions of drospirenone onto the market. With the firm link between Yaz and blood clots, these generic versions of Yaz have the potential to injure more women. Carey Danis & Lowe is concerned about this drug's ability to harm, and with this concern, our defective drug lawyers are closely working alongside our clients to bring them justice, compensation, and relief for injuries, suffering, and pain. If you or someone you love has been injured by Yaz or Yasmin, contact a Carey Danis & Lowe Yaz and Yasmin lawyer. Our Yaz lawyers and Yasmin lawyers are currently offering a free legal evaluation about Yaz and Yasmin cases, and will provide assistance in filing a Yaz lawsuit or a Yasmin lawsuit. Carey Danis & Lowe can be contacted by phone by calling 800.721.2519 or by submitting a legal claim form.

The post Bayer Loses Yaz Patent in Federal Court of Appeals: Generic Yaz Versions Begin (Stealing) Marketshare appeared first on .

Carey Danis & Lowe Pradaxa Lawyers Currently Following Pradaxa MDL 2385

sgodar — Wed, 08 May 2013 14:46:54 +0000

Carey Danis & Lowe Pradaxa lawyers are currently following the Pradaxa multi-district litigation (MDL) in Illinois. The Pradaxa MDL is In re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation MDL no. 2385. The Pradaxa MDL is being heard in the U.S. District Court for the Southern District of Illinois, and is presided over by Chief Judge David R. Herndon. According to Carey Danis & Lowe Pradaxa lawyers, the Pradaxa MDL 2385 continues to move forward with pre-trial proceedings. As documented in minutes from the latest Pradaxa MDL status conference, the plaintiffs' counsel is currently working on deposition scheduling. Also, the defendants' counsel supplied an updated on discovery production. The next Pradaxa MDL status conference is scheduled for May 14, 2013. At the time of writing, the Pradaxa MDL 2385 comprised 486 cases. Pradaxa lawyers at Carey Danis & Lowe are interested to see if this case number will be affected by the recent news of Pradaxa attaining blockbuster status in the pharmaceutical world. Reuters recently reported that Pradaxa sales brought in $1.43 billion in 2012. Though sales of the anticoagulant drug appear to be steady, the number of Pradaxa lawsuits being filed against Boehringer Ingelheim citing serious bleeding injuries and even death continue to increase as well. Carey Danis & Lowe Pradaxa lawyers encourage individuals who have been injured by Pradaxa to contact our law firm today for a free legal evaluation about Pradaxa cases. Our Pradaxa lawyers can also assist with filing Pradaxa lawsuits. Contact Carey Danis & Lowe today by calling 800.721.2519 or by submitting a legal claim form.

The post Carey Danis & Lowe Pradaxa Lawyers Currently Following Pradaxa MDL 2385 appeared first on .